Downloads: 1
Diff of
/processing/MACCROBAT/26530965.ann
[000000]
..
[fd8900]
Switch to unified view
| a | b/processing/MACCROBAT/26530965.ann | ||
|---|---|---|---|
| 1 | T1 Age 2 13 42-year-old |
||
| 2 | T2 Sex 14 19 woman |
||
| 3 | T3 Sign_symptom 50 54 lump |
||
| 4 | E1 Sign_symptom:T3 |
||
| 5 | T4 Biological_structure 37 49 right breast |
||
| 6 | R1 MODIFY Arg1:T4 Arg2:E1 |
||
| 7 | T5 Sign_symptom 67 71 pain |
||
| 8 | E2 Sign_symptom:T5 |
||
| 9 | T6 Biological_structure 56 66 lower back |
||
| 10 | R2 MODIFY Arg1:T6 Arg2:E2 |
||
| 11 | T7 Sign_symptom 73 87 loss of height |
||
| 12 | E3 Sign_symptom:T7 |
||
| 13 | T8 Sign_symptom 96 104 kyphosis |
||
| 14 | E4 Sign_symptom:T8 |
||
| 15 | T9 Sign_symptom 109 121 hepatomegaly |
||
| 16 | E5 Sign_symptom:T9 |
||
| 17 | T10 Diagnostic_procedure 128 136 biopsies |
||
| 18 | E6 Diagnostic_procedure:T10 |
||
| 19 | T11 Biological_structure 146 157 breast lump |
||
| 20 | R3 MODIFY Arg1:T11 Arg2:E6 |
||
| 21 | T12 Disease_disorder 165 181 ductal carcinoma |
||
| 22 | E7 Disease_disorder:T12 |
||
| 23 | T13 Diagnostic_procedure 275 281 biopsy |
||
| 24 | E8 Diagnostic_procedure:T13 |
||
| 25 | T14 Biological_structure 290 321 ipsilateral axillary lymph node |
||
| 26 | R4 MODIFY Arg1:T14 Arg2:E8 |
||
| 27 | T15 Disease_disorder 349 370 ductal adenocarcinoma |
||
| 28 | E9 Disease_disorder:T15 |
||
| 29 | T16 Detailed_description 338 348 metastatic |
||
| 30 | R5 MODIFY Arg1:T16 Arg2:E9 |
||
| 31 | T17 Diagnostic_procedure 399 418 Computed tomography |
||
| 32 | E10 Diagnostic_procedure:T17 |
||
| 33 | T18 Disease_disorder 444 462 metastatic disease |
||
| 34 | E11 Disease_disorder:T18 |
||
| 35 | T19 Biological_structure 466 471 bones |
||
| 36 | R6 MODIFY Arg1:T19 Arg2:E11 |
||
| 37 | T20 Biological_structure 473 479 pleura |
||
| 38 | T21 Biological_structure 484 489 liver |
||
| 39 | R7 MODIFY Arg1:T20 Arg2:E11 |
||
| 40 | R8 MODIFY Arg1:T21 Arg2:E11 |
||
| 41 | T22 Detailed_description 433 443 widespread |
||
| 42 | R9 MODIFY Arg1:T22 Arg2:E11 |
||
| 43 | T23 Medication 581 592 trastuzumab |
||
| 44 | E12 Medication:T23 |
||
| 45 | T24 Medication 597 622 taxane-based chemotherapy |
||
| 46 | E13 Medication:T24 |
||
| 47 | T25 Sign_symptom 651 659 response |
||
| 48 | E14 Sign_symptom:T25 |
||
| 49 | T26 Detailed_description 643 650 partial |
||
| 50 | T27 Detailed_description 631 642 significant |
||
| 51 | R10 MODIFY Arg1:T26 Arg2:E14 |
||
| 52 | R11 MODIFY Arg1:T27 Arg2:E14 |
||
| 53 | T28 Medication 699 711 chemotherapy |
||
| 54 | E15 Medication:T28 |
||
| 55 | T29 Detailed_description 689 698 induction |
||
| 56 | R12 MODIFY Arg1:T29 Arg2:E15 |
||
| 57 | T30 Medication 735 744 tamoxifen |
||
| 58 | E16 Medication:T30 |
||
| 59 | T31 Medication 749 760 trastuzumab |
||
| 60 | E17 Medication:T31 |
||
| 61 | T32 Duration 768 777 19 months |
||
| 62 | E18 Duration:T32 |
||
| 63 | T33 Sign_symptom 811 819 seizures |
||
| 64 | E19 Sign_symptom:T33 |
||
| 65 | T34 Diagnostic_procedure 829 848 computed tomography |
||
| 66 | E20 Diagnostic_procedure:T34 |
||
| 67 | T35 Biological_structure 824 828 head |
||
| 68 | R13 MODIFY Arg1:T35 Arg2:E20 |
||
| 69 | T36 Sign_symptom 866 876 metastasis |
||
| 70 | E21 Sign_symptom:T36 |
||
| 71 | T37 Biological_structure 884 901 left frontal lobe |
||
| 72 | R14 MODIFY Arg1:T37 Arg2:E21 |
||
| 73 | T38 Therapeutic_procedure 935 943 resected |
||
| 74 | E22 Therapeutic_procedure:T38 |
||
| 75 | T39 Medication 965 974 tamoxifen |
||
| 76 | E23 Medication:T39 |
||
| 77 | T40 Medication 979 990 trastuzumab |
||
| 78 | E24 Medication:T40 |
||
| 79 | T41 Diagnostic_procedure 1023 1037 plasma samples |
||
| 80 | E25 Diagnostic_procedure:T41 |
||
| 81 | T42 Date 1069 1086 Four months after |
||
| 82 | E26 Date:T42 |
||
| 83 | T43 Sign_symptom 1120 1127 lesions |
||
| 84 | E27 Sign_symptom:T43 |
||
| 85 | T44 Biological_structure 1114 1119 liver |
||
| 86 | T45 Detailed_description 1104 1113 enlarging |
||
| 87 | R15 MODIFY Arg1:T44 Arg2:E27 |
||
| 88 | R16 MODIFY Arg1:T45 Arg2:E27 |
||
| 89 | T46 Sign_symptom 1138 1156 metastatic deposit |
||
| 90 | E28 Sign_symptom:T46 |
||
| 91 | T47 Biological_structure 1164 1174 left ovary |
||
| 92 | R17 MODIFY Arg1:T47 Arg2:E28 |
||
| 93 | T48 Medication 1241 1250 lapatinib |
||
| 94 | E29 Medication:T48 |
||
| 95 | T49 Medication 1255 1267 capecitabine |
||
| 96 | E30 Medication:T49 |
||
| 97 | T50 Sign_symptom 1282 1296 stable disease |
||
| 98 | E31 Sign_symptom:T50 |
||
| 99 | T51 Duration 1301 1310 12 months |
||
| 100 | E32 Duration:T51 |
||
| 101 | T52 Sign_symptom 1334 1355 General deterioration |
||
| 102 | E33 Sign_symptom:T52 |
||
| 103 | T53 Sign_symptom 1376 1395 disease progression |
||
| 104 | E34 Sign_symptom:T53 |
||
| 105 | T54 Biological_structure 1403 1408 chest |
||
| 106 | R18 MODIFY Arg1:T54 Arg2:E34 |
||
| 107 | T55 Disease_disorder 1443 1460 pleural effusions |
||
| 108 | E35 Disease_disorder:T55 |
||
| 109 | T56 Detailed_description 1433 1442 bilateral |
||
| 110 | R19 MODIFY Arg1:T56 Arg2:E35 |
||
| 111 | T57 Sign_symptom 1424 1431 nodules |
||
| 112 | E36 Sign_symptom:T57 |
||
| 113 | T58 Biological_structure 1414 1423 pulmonary |
||
| 114 | R20 MODIFY Arg1:T58 Arg2:E36 |
||
| 115 | T59 Sign_symptom 1486 1490 mass |
||
| 116 | E37 Sign_symptom:T59 |
||
| 117 | T60 Biological_structure 1465 1485 posterior chest wall |
||
| 118 | R21 MODIFY Arg1:T60 Arg2:E37 |
||
| 119 | T61 Outcome 1611 1615 died |
||
| 120 | E38 Outcome:T61 |
||
| 121 | T62 Therapeutic_procedure 1573 1582 Treatment |
||
| 122 | E39 Therapeutic_procedure:T62 |
||
| 123 | A1 POLARITY E39 NEG |
||
| 124 | T63 Date 1617 1631 4 months later |
||
| 125 | E40 Date:T63 |
||
| 126 | T64 Clinical_event 20 29 presented |
||
| 127 | E41 Clinical_event:T64 |
||
| 128 | * OVERLAP E41 E1 E2 E3 E4 E5 E6 E7 E8 E9 E10 E11 |
||
| 129 | R22 BEFORE Arg1:E11 Arg2:E12 |
||
| 130 | * OVERLAP E12 E13 E14 E15 |
||
| 131 | R23 BEFORE Arg1:E15 Arg2:E16 |
||
| 132 | * OVERLAP E16 E17 E18 |
||
| 133 | R24 BEFORE Arg1:E18 Arg2:E19 |
||
| 134 | * OVERLAP E19 E20 E21 E22 |
||
| 135 | R25 BEFORE Arg1:E22 Arg2:E23 |
||
| 136 | * OVERLAP E23 E24 E25 |
||
| 137 | R26 BEFORE Arg1:E25 Arg2:E26 |
||
| 138 | * OVERLAP E26 E27 E28 |
||
| 139 | R27 BEFORE Arg1:E28 Arg2:E29 |
||
| 140 | * OVERLAP E29 E30 |
||
| 141 | R28 BEFORE Arg1:E30 Arg2:E31 |
||
| 142 | * OVERLAP E31 E32 |
||
| 143 | R29 BEFORE Arg1:E32 Arg2:E33 |
||
| 144 | * OVERLAP E33 E34 E36 E35 E37 E42 |
||
| 145 | T65 Diagnostic_procedure 1513 1566 Eastern Cooperative Oncology Group performance status |
||
| 146 | E42 Diagnostic_procedure:T65 |
||
| 147 | T66 Lab_value 1567 1570 2–3 |
||
| 148 | R30 MODIFY Arg1:T66 Arg2:E42 |
||
| 149 | R31 BEFORE Arg1:E42 Arg2:E39 |
||
| 150 | R32 BEFORE Arg1:E39 Arg2:E38 |
||
| 151 | * OVERLAP E38 E40 |